Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000456
Status:
COMPLETED
Last Update Posted:
2010-10-04
First Post:
1999-11-02
Brief Title:
Behavioral Therapy Plus Naltrexone for Alcoholism
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Study Overview
Official Title:
Comparison of Cognitive Behavioral Therapy and Motivational Enhancement Therapy Plus Naltrexone for Alcoholism
Status:
COMPLETED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare cognitive behavioral therapy with a time-limited motivational enhancement therapy to which naltrexone Revia or placebo medication is added In this randomized clinical trial 160 alcohol-dependent outpatients after 5 days of abstinence will receive one of the two psychosocial therapies and either naltrexone Revia or placebo for a 12-week treatment period Abstinence rates alcohol use and time to alcohol relapse will be evaluated in all four groups along with measures of alcohol craving biological measures of alcohol consumption drinking consequences changes in self-confidence for avoiding alcohol and medication compliance All study participants will be assessed for measures of outcome variables at 3 and 6 months after completing the treatment protocol
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01AA009568 | NIH | None | httpsreporternihgovquickSearchR01AA009568 |